Differential requirement of CAAX-mediated posttranslational processing for Rheb localization and signaling von Hanker, A B, Mitin, N, Wilder, R S, Henske, E P, Tamanoi, F, Cox, A D, Der, C J

Volltext

Neratinib plus fulvestrant plus trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial von Jhaveri, K, Eli, L.D, Wildiers, H, Hurvitz, S.A, Guerrero-Zotano, A, Unni, N, Brufsky, A, Park, H, Waisman, J, Yang, E.S, Spanggaard, I, Reid, S, Burkard, M.E, Vinayak, S, Prat, A, Arnedos, M, Bidard, F.-C, Loi, S, Crown, J, Bhave, M, Piha-Paul, S.A, Suga, J.M, Chia, S, Saura, C, Garcia-Saenz, J.A, Gambardella, V, de Miguel, M.J, Gal-Yam, E.N, Raphael, A, Stemmer, S.M, Ma, C, Hanker, A.B, Ye, D, Goldman, J.W, Bose, R, Peterson, L, Bell, J.S.K, Frazier, A, Diprimeo, D, Wong, A, Arteaga, C.L, Solit, D.B

Volltext

579 POSTER Biological and biochemical activity of TLN-4601 in pancreatic cancer von Campbell, P.M, Fiordalisi, J.J, Hanker, A.B, Boufaied, N, Gourdeau, H, Falardeau, P, Cox, A.D, Der, C.J

Volltext